title: Fat feeding increases equine heparin-released lipoprotein lipase activity.
abstract: The aim of this study was to establish the dose-response relationship between fat intake and heparin-released plasma lipoprotein lipase (LPL) activity in horses. Eight mature trotters were fed 4 rations with different fat levels (3.0, 5.0, 7.7, or 10.8% fat in the dry matter) according to a 4 X 4 Latin square design. The experimental rations consisted of hay and different concentrates; the concentrates and hay were given in a 3:1 ratio on an energy basis. Soybean oil was added to the concentrates at the expense of isoenergetic amounts of glucose. Blood samples were taken at the end of each dietary period, which lasted 3 weeks. Fat feeding was found to increase heparin-released plasma LPL activity in a dose-dependent fashion. When the data from this study and previous studies were combined it was calculated that an increase in fat intake by 1 g/kg dry matter is associated with an increase in LPL activity by 0.98 micromol fatty acid released-mL(-1) x h(-1). Fat feeding raised the plasma concentrations of total cholesterol, high-density lipoprotein cholesterol, and phospholipids. Diet did not have a statistically significant effect on plasma triacylglycerol concentrations. The results are discussed in the light of the possible enhancing effect of fat feeding on the oxidative capacity of skeletal muscle.
authors.affiliation: Department of Equine Sciences, Faculty of Veterinary Medicine, Utrecht University, The Netherlands. suzannegeelen@hotmail.com
authors.forename: S N
authors.initials: SN
authors.lastname: Geelen
authors.forename: W L
authors.initials: WL
authors.lastname: Jansen
authors.forename: M M
authors.initials: MM
authors.lastname: Sloet van Oldruitenborgh-Oosterbaan
authors.forename: H J
authors.initials: HJ
authors.lastname: Breukink
authors.forename: A C
authors.initials: AC
authors.lastname: Beynen
mesh_terms: D000222:Adaptation, Physiological; D000821:Animal Feed; D000818:Animals; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D018592:Cross-Over Studies; D004041:Dietary Fats / Q000008:administration & dosage / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006493:Heparin / Q000008:administration & dosage / Q000494:pharmacology; D006736:Horses / Q000097:blood*; D007275:Injections, Intravenous / Q000662:veterinary; D016014:Linear Models; D008071:Lipoprotein Lipase / Q000097:blood* / Q000187:drug effects*; D008099:Liver / Q000378:metabolism; D008297:Male; D010743:Phospholipids / Q000097:blood; D011897:Random Allocation; D014280:Triglycerides / Q000097:blood / Q000378:metabolism
chemical_list: D008076:Cholesterol, HDL; D004041:Dietary Fats; D010743:Phospholipids; D014280:Triglycerides; D006493:Heparin; D002784:Cholesterol; D008071:Lipoprotein Lipase